newsfilter
← Latest News
GlobeNewswire·

Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.

Name change to "Climb Bio" marks the Company's transition and focus on developing treatments for immune-mediated diseases Climb Bio will begin trading on Nasdaq under the trading symbol "CLYM"